These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Antisense drug discovery and development. Yamamoto T; Nakatani M; Narukawa K; Obika S Future Med Chem; 2011 Mar; 3(3):339-65. PubMed ID: 21446846 [TBL] [Abstract][Full Text] [Related]
15. Morpholino antisense oligomers: the case for an RNase H-independent structural type. Summerton J Biochim Biophys Acta; 1999 Dec; 1489(1):141-58. PubMed ID: 10807004 [TBL] [Abstract][Full Text] [Related]
16. In vitro transcription and translation inhibition via DNA functionalized gold nanoparticles. Conde J; de la Fuente JM; Baptista PV Nanotechnology; 2010 Dec; 21(50):505101. PubMed ID: 21098932 [TBL] [Abstract][Full Text] [Related]
17. By-passing the nonsense mutation in the 4 CV mouse model of muscular dystrophy by induced exon skipping. Mitrpant C; Fletcher S; Iversen PL; Wilton SD J Gene Med; 2009 Jan; 11(1):46-56. PubMed ID: 19006096 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans. Iversen PL; Arora V; Acker AJ; Mason DH; Devi GR Clin Cancer Res; 2003 Jul; 9(7):2510-9. PubMed ID: 12855625 [TBL] [Abstract][Full Text] [Related]
19. Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides. Agrawal S Biochim Biophys Acta; 1999 Dec; 1489(1):53-68. PubMed ID: 10806997 [TBL] [Abstract][Full Text] [Related]